Anatomie, Physiologie, Pathophysiologie

  • P. Schmidt
  • K. P. Jünemann
  • H. Derouet
  • W. H. Jost
  • S. Ückert
  • G. Popken
  • U. Wetterauer
  • H. M. Behre
  • U. Hartmann
  • W. F. Thon

Zusammenfassung

Voraussetzung für die Therapie einer Erektionsstorung ist die Kenntnis der anatomischen Strukturen und physiologischen Abläufe, die für das Entstehen, Aufrechterhalten und den Ruckgang der Erektion von Bedeutung sind. Dabei ist es historisch interessant, daß bis Ende der 7oer Jahre dieses Jahrhunderts Erektionsstorungen als überwiegend psychogen klassifiziert wurden, obwohl bereits Eckhard 1863 und spater v. Ebner erste physiologische Untersu-chungen des Erektionsablaufs duchgeführt hatten [3, 4]. Diese Erkenntnisse gerieten leider lange Jahrzehnte in Vergessenheit. Erst die Moglichkeit der Induktion einer artifiziellen Erektion durch Injektion vasoaktiver Substanzen sollte das anatomische und physiologische Grundverständnis des Erektionsablaufs ändern und die bis dato geltende Lehrmeinung einer arteriellen Shunt -therorie in Frage stellen [2].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Comarr AE (1970) Sexual function among patients with spinal cord injury. Urol Int 25: 134–168PubMedCrossRefGoogle Scholar
  2. 2.
    Conti G (1952) L’érection du penis humain et ses bases morphologico-vasculaires. Acta Anat 14:217PubMedCrossRefGoogle Scholar
  3. 3.
    Ebner V von (1900) Über klappenartige Vorrichtungen in den Arterien der Schwellkorper. Anat Anz 18:79Google Scholar
  4. 4.
    Eckhard C (1863) Untersuchungen uber die Erektion beim Hunde. Beitr Anat Physiol 3:123Google Scholar
  5. 5.
    Fournier GR Jr, Juenemann KP, Lue TF, Tanagho EA (1987) Mechanisms of venous occlusion during canine penile erection: an anatomic demonstration. J Urol 137:163–167PubMedGoogle Scholar
  6. 6.
    Jiinemann KP (1988) Physiologie der penilen Erektion. In: Bähren W, Altwein JE (Hrsg) Impotenz. Diagnostik und Therapie in Klinik und Praxis. Thieme, StuttgartGoogle Scholar
  7. 7.
    Jünemann KP (1992) Erektionsstorungen. In: Alken P, Walz K (Hrsg) Urologie. VCH, Weinheim, Kap. 12Google Scholar
  8. 8.
    Jünemann KP, Lue TF, Abozeid M, Hellstrom WJ, Tanagho EA (1986) Blood gas analysis in drug-induced penile erection. Urol Int 41:207–211CrossRefGoogle Scholar
  9. 9.
    Jünemann KP, Lue TF, Fournier GR Jr, Tanagho EA (1986) Hemodynamics of papaverine-and phentolamine-induced penile erection. J Urol 136:158 –161Google Scholar
  10. 10.
    Jünemann KP, Luo JA, Lue TF, Tanagho EA (1986) Further evidence of venous outflow restriction during erection. Br J Urol 58:320–324CrossRefGoogle Scholar
  11. 11.
    Jünemann KP, Persson-Jünemann C, Lue TF, Tanagho EA, Alken P (1989) Neurophysio-logical aspects of penile erection. Brit J Urol 64:84–92PubMedCrossRefGoogle Scholar
  12. 12.
    Jünemann KP, Persson-Jünemann C, Tanagho EA, Alken P (1989) Neurophysiology of penile erection. Urol Res 17:213 – 217PubMedCrossRefGoogle Scholar
  13. 13.
    Lavoisier P, Courtois F, Barres D, Blanchard M (1986) Correlation between intracavernous pressure and contraction of the ischiocavernosus muscle in man. J Urol 136:936 – 939PubMedGoogle Scholar
  14. 14.
    Lue TF, Takamura T, Schmidt RA, Palubinskas AJ, Tanagho EA (1983) Hemodynamics of erection in the monkey. J Urol 130:1237–1241PubMedGoogle Scholar
  15. 15.
    Lue TF, Zeineh SJ, Schmidt RA, Tanagho EA (1983) Physiology of penile erection. World J Urol 1:194CrossRefGoogle Scholar
  16. 16.
    Lue TF, Takamura T, Umraiya M, Schmidt RA, Tanagho EA (1984) Hemodynamics of canine corpora cavernosa during erection. Urology 24:347–352PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Aboseif SR, Wetterauer U, Breza J et al. (1990) The effect of venous incompetence and arterial insufficiency on erectile function: an animal model. J Urol 144:790–793PubMedGoogle Scholar
  2. 2.
    Angermann I (1980) Psychodynamik und Psychotherapie der gestorten Sexualitat. In: Eicher W (Hrsg) Sexualmedizin in der Praxis. Fischer, StuttgartGoogle Scholar
  3. 3.
    Bähren W, Gall H, Scherb W, Holzki G, Sparwasser C (1991) Pharmacoarteriography in chronic erectile dysfunction. In: Jonas U et al. (eds) Erectile dysfunction. Springer, Berlin Heidelberg New York Tokyo, pp 34–43Google Scholar
  4. 4.
    Bartsch G, Scheiber K (1983) Endocrinologic aspects of disturbed potency. World J Urol 1:197–202CrossRefGoogle Scholar
  5. 5.
    Becker N (1975) Psychoanalytische Ansatze bei der Therapie sexueller Funktionsstörungen. In: Sigusch V (Hrsg) Therapie sexueller Störungen. Thieme, StuttgartGoogle Scholar
  6. 6.
    Brindley GS (1983) Cavernousal alpha-blockade: a new technique for investigating and treating erectile impotence. Brit J Psychiat 143:332PubMedCrossRefGoogle Scholar
  7. 7.
    DePalma RG, Levine SB, Feldmann S (1978) Preservation of erectile function after aortoiliac reconstruction. Arch Surg 113:958PubMedCrossRefGoogle Scholar
  8. 8.
    Ellenberg M (1971) Impotence in diabetes: the neurologic factor. Ann Intern Med 75:213PubMedGoogle Scholar
  9. 9.
    Jevtich MJ, Kass M, Khawand N (1985) Changes in the corpora cavernosa of impotent diabetics. Comparing histological with clinical findings. J Urol (Paris) 91:281Google Scholar
  10. 10.
    Jünemann KP, Lue TF, Luo JA, Benowitz NL, Abozeid M, Tanagho EA (1987) The effect of cigarette smoking on penile erection. J Urol 138:438 – 441Google Scholar
  11. 11.
    Jünemann KP, Lue TF, Melchior H (1987) Die Physiologie der penilen Erektion. II. Neurophysiologie der penilen Erektion. Urologe [A] 26:283 – 288Google Scholar
  12. 12.
    Kockott G (1981) Sexuelle Funktionsstorungen des Mannes. Enke, Stuttgart (Beitr Sexual-forsch 58)Google Scholar
  13. 13.
    Leriche R, Morel A (1948) The syndrome of thrombotic obliteration of the aortic bifurcation. Ann Surg 127:193CrossRefGoogle Scholar
  14. 14.
    Lue TF, Zeineh SJ, Schmidt A, Tanagho EA (1984) Neuroanatomy of penile erection: its relevance to iatrogenic impotence. J Urol 131:273PubMedGoogle Scholar
  15. 15.
    Matussek P (1971) Funktionelle Sexualstörungen. In: Giese H (Hrsg) Die Sexualität des Menschen. Enke, StuttgartGoogle Scholar
  16. 16.
    May AG, DeWeese JA, Rob CG (1969) Changes in sexual function following operation on the abdominal aorta. Surgery 65:41PubMedGoogle Scholar
  17. 17.
    Metz P, Herning M (1984) Impotence and aorto-iliac disease with special reference to the pelvic steal syndrome. Int Angiol 3:259Google Scholar
  18. 18.
    Nath RL, Menzoian JO, Kaplan KH, McMillian TN, Siroky MB, Krane RJ (1981) The multidisciplinary approach to vasculogenic impotence. Surgery 89:124PubMedGoogle Scholar
  19. 19.
    Nickel CJ, Morales A, Condra M, Fenemore J, Surridge DH (1984) Endocrine dysfunction in impotence: incidence, significance and cost-effective screening. J Urol 132:40 – 43PubMedGoogle Scholar
  20. 20.
    Porst H, Ahlen HV, Leipner N, Köster O (1986) Dynamische Kavernosographie. Fortschr Röntgenstr 145:80CrossRefGoogle Scholar
  21. 21.
    Rotter W, Schürmann R (1950) Die Blutgefafäße des menschlichen Penis. Arch Path Anat 318:352CrossRefGoogle Scholar
  22. 22.
    Staubesand J, Wetterauer U, Kuvelis F (1991) Ultrastuctural findings in patients with erectile dysfunction. In: Jonas U et al. (eds) Erectile dysfunction. Springer, Berlin Heidelberg New York Tokyo, pp 34–43Google Scholar
  23. 23.
    Stief CG, Thon WF, Gall H, Scherb W, Schnell D, Altwein JE, Bahren W (1987) Die venose Insuffizienz der Corpora cavernosa als (Mit-)Ursache der erektilen Dysfunktion. Urologe [A] 26:83Google Scholar
  24. 24.
    Virag R (1982) Intracavernous injection injection of papaverine for erectile failure. Lancet 11:938CrossRefGoogle Scholar
  25. 25.
    Virag R, Frydman D, Legman M, Floresco J, Bouilly P (1984) Hemodynamic evaluation of arterial and venous lesions as a cause of impotence. Int Angiol 3:241Google Scholar
  26. 26.
    Wagner G (1984) Vascular mechanism involved in human erection. Int Angiol 3:221Google Scholar
  27. 27.
    Walsh PC, Donker PJ (1982) Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 128:492PubMedGoogle Scholar
  28. 28.
    Wetterauer U, Stief CG, Kuvelis F, Staubesand J, Sommerkamp H (1989) Ultrastukturelle Veranderungen des cavernosen Gewebes und der Tunica albuginea bei erektiler Impotenz. Verh Ber Dt Ges Urol 27:356–358Google Scholar

Literatur

  1. 1.
    Anderson RA, Bancroft J, Wu FCW (1992) The effects of exogenous testosterone on sexuality and mood of normal men. J Clin Endocrinol Metab 75:1503–1507PubMedCrossRefGoogle Scholar
  2. 2.
    Behre HM, Nieschlag E (1992) Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester. J Clin Endocrinol Metab 75:1204 –1210PubMedCrossRefGoogle Scholar
  3. 3.
    Behre HM, Böckers A, Schlingheider A, Nieschlag E (1994) Sustained suppression of serum LH, FSH, and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men. Clin Endocrinol 40:241–248CrossRefGoogle Scholar
  4. 4.
    Behre HM, Yeung CH, Nieschlag E (1996) Diagnostik der Infertiliät und des Hypogona-dismus. In: Nieschlag E, Behre HM (Hrsg) Andrologie — Grundlagen und Klinik der reproduktiven Gesundheit des Mannes. Springer, Berlin Heidelberg New York, S 89–117Google Scholar
  5. 5.
    Buena F, Peterson MA, Swerdloff RS et al. (1993) Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal range. J Clin Endocrinol Metab 59:1118–1123Google Scholar
  6. 6.
    Christiansen K (1998) Behavioural correlates of testosterone. In: Nieschlag E, Behre HM (eds) Testosterone — action, deficiency, substitution, 2nd edn. Springer, Berlin Heidelberg New York Tokyo, pp 107–142Google Scholar
  7. 7.
    Davidson JM, Camargo CA, Smith ER (1979) Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab 48:955–958PubMedCrossRefGoogle Scholar
  8. 8.
    Deutsche Gesellschaft für Endokrinologie (Hrsg) (1993) Rationelle Diagnostik in der Endokrinologie einschlieülich Diabetologie und Stoffwechsel. Thieme, StuttgartGoogle Scholar
  9. 9.
    Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 151:54–61PubMedGoogle Scholar
  10. 10.
    Gooren LJ (1987) Androgen levels and sex functions in testosterone-treated hypogonadal men. Arch Sex Behav 16:463–473PubMedCrossRefGoogle Scholar
  11. 11.
    Hubert W (1990) Psychotropic effects of testosterone. In: Nieschlag E, Behre HM (eds) Testosterone — action, deficiency, substitution. Springer, Berlin Heidelberg New York Tokyo, pp 51–71Google Scholar
  12. 12.
    Korenman SG, Morley JE, Mooradian AD et al. (1990) Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab 71:963–969PubMedCrossRefGoogle Scholar
  13. 13.
    Martini L, Melcangi C, Celotti F (1992) Androgens and the brain: role of testosterone metabolism. In: Nieschlag E, Habenicht UF (eds) Spermatogenesis – fertilization – contraception. Molecular, cellular and endocrine events in male reproduction. Springer, Berlin Heidelberg New York Tokyo, pp 123 —142Google Scholar
  14. 14.
    Mooradian AD, Morley JE, Korenman SG (1987) Biological actions of androgens. Endocr Rev 8:1–28PubMedCrossRefGoogle Scholar
  15. 15.
    O’Carroll R, Shapiro C, Bancroft J (1985) Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose. Clin Endocrinol 23: 527–538CrossRefGoogle Scholar
  16. 16.
    Tschöp M, Behre HM, Nieschlag E, Dressendörfer RA, Strasburger CJ (1998) A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: monitoring of testosterone replacement therapy with testosterone buciclate. J Clin Chem Clin Biochem 36:223–230Google Scholar
  17. 17.
    Tsitouras PD, Martin CE, Harman AM (1982) Relationship of serum testosterone to sexual activity in healthy elderly men. J Gerontol 37:288–293PubMedGoogle Scholar
  18. 18.
    Vermeulen A, Verdonck G (1992) Representativeness of a single point plasma testosterone level for the long term hormonal milieu. J Clin Endocrinol Metab 74:939–942PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Althof SE (1989) Psychogenic impotence: treatment of men and couples. In: Leiblum SR, Rosen RC (eds) Principles and practice of sex therapy. Update for the 1990s. Guilford, New YorkGoogle Scholar
  2. 2.
    Bancroft J (1993) But what is psychogenic erectile dysfunction? Int J Impot Res 5:205–206Google Scholar
  3. 3.
    Bancroft J (1994) What is psychogenic erectile dysfunction? Paper presented at the 2nd Conference of the European Federation of Sexology, CopenhagenGoogle Scholar
  4. 4.
    Barlow DH (1986) Causes of sexual dysfunctions: the role of anxiety and cognitive interference. J of Consult Clin Psychol 54:140–148CrossRefGoogle Scholar
  5. 5.
    Fenichel O (1980) Psychoanalytische Neurosenlehre, Bd I. Olten, FreiburgGoogle Scholar
  6. 6.
    Freud S (1910) Über die allgemeinste Erniedrigung des Liebeslebens. (Gesammelte Werke, Bd 8; Fischer, Frankfurt/M, 1964)Google Scholar
  7. 7.
    Hartmann U (1994) Diagnostik und Therapie der erektilen Dysfunktion. Theoretische Grundlagen und Praxisempfehlungen aus einer multidisziplinaren Spezialsprechstunde. Lang, Frankfurt/MGoogle Scholar
  8. 8.
    Hartmann U (1995) Die kombinierte psycho-somatische Behandlung erektiler Dysfunk-tionen. Psycho 21:651–657Google Scholar
  9. 9.
    Hartmann U (1997) Psychological subtypes of erectile dysfunctions: results from statistical analyses and clinical practice. World J Urol 15:56–64PubMedCrossRefGoogle Scholar
  10. 10.
    Janssen E, Everaerd W (1993) Determinants of male sexual arousal. In: Bancroft J (ed) Annual review of sex research, vol 4. Mount Vernon: SSSS, pp 211–245Google Scholar
  11. 11.
    Janssen E, Bancroft J (1996): Dual control of sexual response: the relevance of central inhibition. Paper presented at the 22nd Meeting of the International Academy of Sex Research, RotterdamGoogle Scholar
  12. 12.
    Kaplan HS (1974) The new sex therapy. Brunner & Mazel, New YorkGoogle Scholar
  13. 13.
    Kaplan HS (1981) Hemmungen der Lust. Enke, StuttgartGoogle Scholar
  14. 14.
    Langer D, Hartmann U (1992) Psychosomatik der Impotenz. Enke, StuttgartGoogle Scholar
  15. 15.
    Levine SB (1992) Intrapsychic and interpersonal aspects of impotence: psychogenic erectile dysfunction. In: Rosen RC, Leiblum SR (eds) Erectile disorders. Assessment and treatment. Guilford, New YorkGoogle Scholar
  16. 16.
    Levine SB, Althof SE (1991) The pathogenesis of psychogenic erectile dysfunction. J Sex Educat Ther 17:251Google Scholar
  17. 17.
    Lue TF (1993) Erectile dysfunction: Problems and challenges. J Urol 149:1256–1257PubMedGoogle Scholar
  18. 18.
    Masters WH, Johnson VE (1970) Human sexual inadequacy. Little & Brown, Boston (Deutsch: Impotenz und Anorgasmie; Goverts, Frankfurt/M, 1973)Google Scholar
  19. 19.
    National Institutes of Health (1992) Consensus Development Conference Statement on Impotence. National Institutes of Health, BethesdaGoogle Scholar

Literatur

  1. 1.
    Amiel SA (1993) Diabetic control and complications. BMJ 307/6909:881–882PubMedCrossRefGoogle Scholar
  2. 2.
    Andersson KE, Stief CG (1997) Neurotransmission and the contraction and relaxation of penile erectile tissues. World J Urol 15:14–20PubMedCrossRefGoogle Scholar
  3. 3.
    Atkinson MA, MacLaren NK (1994) The pathogenesis of insulin-dependent diabetes mel-litus. N Engl J Med 331/21:1428–1436PubMedCrossRefGoogle Scholar
  4. 4.
    Bancroft J, Gutierrez P (1996) Erectile dysfunction in men with and without diabetes mel-litus: a comparative study. Diab Med 13/8:84–89CrossRefGoogle Scholar
  5. 5.
    Bemelmans BL, Meuleman EJ, Doesburg WH, Notermans SL, Debruyne FM (1994) Erectile dysfunction in diabetic men: the neurological factor revisited. J Urol 151/4: 884–889PubMedGoogle Scholar
  6. 6.
    Bishop JR, Moul JW, Sihelnik SA, Peppas DS, Gormley TS, McLeod DG (1992) Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprostehtic infections. J Urol 147:386–388PubMedGoogle Scholar
  7. 7.
    Blanco R, Saenz de Tejada IS, Goldstein I, Frane RJ, Wotiz HH, Cohen RA (1990) Dysfunctional penile cholinergic nerves in diabetic impotent men. J Urol 144:278–280PubMedGoogle Scholar
  8. 8.
    Bodansky HJ (1994) Treatment of male erectile dysfunction using the active vacuum assist device. Diabet-Med 11/4:410–412PubMedCrossRefGoogle Scholar
  9. 9.
    Burnett AL, Lowenstein CJ, Bredt D, Chang TSK, Snyder SH (1992) Nitric oxide: a physiologic mediator of penile erection. Science 257:401–403PubMedCrossRefGoogle Scholar
  10. 10.
    Buvat J, Lemaire A, Buvat-Herbaut M, Guien JD, Bailleul JP, Fossati P (1985) Comparative investigations in 26 impotent and 26 nonimpotent diabetic patients. J Urol 133/8:34–38PubMedGoogle Scholar
  11. 11.
    Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK (1994) Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non- diabetic and streptozotocin-diabetic rats. Diabetologia 37:449–459PubMedCrossRefGoogle Scholar
  12. 12.
    Ceriello A, Quatraro A, Caretta F, Varano R, Giugliano D (1990) Evidence for a possible role of oxygen free radicals in the abnormal functional arterial vasomotion in insulin-dependent diabetes. Diabetes Metab 16:318–322Google Scholar
  13. 13.
    Cohen RA (1993) Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 [Suppl V]: 67–76Google Scholar
  14. 14.
    DePalma RG (1997) Vascular surgery for impotence: a review. Int J Imp Res 9:61–67CrossRefGoogle Scholar
  15. 15.
    Diabetes Epidemiology Research International Mortality Study Group (1991) Major cross-country differences in risk of dying for people with IDDM. Diabetes Care 14: 49–54CrossRefGoogle Scholar
  16. 16.
    Djamilian MH, Stein J, Fröhlich T, Stief CG, Thon WF (1997) Intrakavernose Phenyl-ephrininjektion bei pharmakologisch induzierter prolongierter Erektion. Urologe [B] 37: 45–47CrossRefGoogle Scholar
  17. 17.
    Earle CM, Seah M, Coulden SE, Stuckey BGA, Keogh EJ (1996) The use of the vacuum erection device in the mangement of erectile dysfunction. Int J Imp Res 8/4:237–240Google Scholar
  18. 18.
    Ebbehoj J, Wagner G (1979) Insufficient penile erection due to abnormal drainage of cavernous bodies. Urology 13:507–510PubMedCrossRefGoogle Scholar
  19. 19.
    el-Bahrawy M, el-Baz MA, Emam A, el-Magd MA (1995) Noninvasive vacuum constriction device in the mangement of erectile dysfunction. Int J Urol 27/3:331–333Google Scholar
  20. 20.
    Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285:916–918CrossRefGoogle Scholar
  21. 21.
    Fairburn CG, McCulloch DK, Wu FC (1982) The effects of diabetes on male sexual function. Clin Endocrinol Metab 11/8:749–767PubMedCrossRefGoogle Scholar
  22. 22.
    Francavilla S, Properzi G, Bellini C, Marino G, Ferri C, Santucci A (1997) Endothelin-1 in diabetic and non-diabetic men with erectile dysfunction. I Urol 158:1770–1774Google Scholar
  23. 23.
    Gilbert P, Sparwasser C, Beckert R, Treiber U, Pust R (1992) Venous surgery in erectile dysfunction. Urol Int 49:40–47PubMedCrossRefGoogle Scholar
  24. 24.
    Giugliano D, Ceriello A (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19/3:257–267PubMedCrossRefGoogle Scholar
  25. 25.
    Gorek M, Stief CG, Hartung C, Jonas U (1997) Computer assisted interpretation of electromyograms of corpora cavernosa using fuzzy logic. World J Urol 15:65–70PubMedCrossRefGoogle Scholar
  26. 26.
    Harrison DG (1993) Endothelial dysfunction in the coronary microcirculation: a new clinical entity or an experimental finding? J Clin Ivest 91:1–2CrossRefGoogle Scholar
  27. 27.
    Hirshkowitz M, Karacan I, Rando KC, Williams RL, Howell JW (1990) Diabetes, erectile dysfunction, and sleep related erections. Sleep 13:53–68PubMedGoogle Scholar
  28. 28.
    Hosking DJ, Bennet D, Hampton JR, Evans DF, Clark AJ, Robertson G (1979) Diabetic impotence: studies of nocturnal erection during REM sleep. Br Med J 2:1394–1396PubMedCrossRefGoogle Scholar
  29. 29.
    Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J (1990) Nitric oxide and cyclic GMP formation upon electric field stimulation cause relaxation of corpus caverno-sum smooth muscle. Biochem Biophys Res Commun 170:843–850PubMedCrossRefGoogle Scholar
  30. 30.
    Jarow JP (1996) Risk factors for penile prostehtic infection. J Urol 156:402–404PubMedCrossRefGoogle Scholar
  31. 31.
    Jarow JP, DeFranzo AJ (1996) Long-term results of arterial bypass surgery for impotence secondary to segmental vascular disease. J Urol 156:982–985PubMedCrossRefGoogle Scholar
  32. 32.
    Jensen SB (1981) Diabetic sexual function: a comparative study of 160 insulin treated diabetic men and women, and an aged matched controll group. Arch Sex Behav 10: 493–504PubMedCrossRefGoogle Scholar
  33. 33.
    Jensen SB (1986) Sexual dysfunction in insulin treated diabetics: a six year follow-up study of 101 patients. Arch Sex Behav 15:271–284PubMedCrossRefGoogle Scholar
  34. 34.
    Kadioglu A, Erdogru T, Kardisag K, Dinccag N, Satman I, Yilmaz T, Tellaloglu S (1995) Evaluation of penile arterial system with color Doppler ultrasonography in nondiabetic and diabetic males. Eur Urol 27/4:311–314PubMedGoogle Scholar
  35. 35.
    Klein R, Klein BEK, Lee KE, Moss SE, Cruickshanks KJ (1996) Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 19/2:135 –141PubMedCrossRefGoogle Scholar
  36. 36.
    Kuuisisto J, Mykkanen L, Pyorala K, Laakso M (1994) NIDDM and ist metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960–967CrossRefGoogle Scholar
  37. 37.
    LaPorte RE, Cruickshanks KJ (1985) Incidence and risk factors for insulin dependent diabetes. In: National Diabets Data Group (ed) Diabetes in America: diabetes data compiled 1984. Bethesda, Md. Dept Health and Human Services, III-1-III-12 (NIH publication no. 85–1468)Google Scholar
  38. 38.
    Lewis RW, Witherington R (1997) External vacuum therapy for erectile dysfunction. World J Urol 15:78–82PubMedCrossRefGoogle Scholar
  39. 39.
    Lorenzi M, Montisano DF, Toledo S, Barrieux A (1986) High glucose induces DNA damage in cultured human endothelial cells. J Clin Invest 77:322–325PubMedCrossRefGoogle Scholar
  40. 40.
    Low PA, Tuck RR, Takeuchi M (1987) Nerve microenviroment in diabetic neuropathy. In: Dyck PJ (ed) Diabetic neuropathy. Saunders, Philadelphia, pp 266–278Google Scholar
  41. 41.
    Lue TF, Tanagho EA (1987) Physiology of erection and pharmacological management of impotence. J Urol 137:829–836PubMedGoogle Scholar
  42. 42.
    Lue TF, Hricak H, Schmidt RA, Tanagho EA (1986) Functional evaluation of penile veins by cavernosography and papaverine-induced erection. J Urol 135:479–486PubMedGoogle Scholar
  43. 43.
    Lugg JA, Rajfer J, Gonzalez-Cadavid NF (1995) The role of nitric oxide in erectile dysfunction. J Androl 16:2–5PubMedGoogle Scholar
  44. 44.
    Lustman PJ, Clouse RE (1990) Relationsship of psychiatric illness to impotence in men with diabetes. Diabetes Care 13:893–895PubMedCrossRefGoogle Scholar
  45. 45.
    Lynch MJ, Scott GM, Inglis JA, Pryor JP (1994) Reducing the loss of implants following penile prosthetic surgery. Br J Urol 73:423–427PubMedCrossRefGoogle Scholar
  46. 46.
    Marsiglio W, Donnely D (1991) Sexual relations in later life: A national study of married persons. J Gerontol 46:338–344Google Scholar
  47. 47.
    McCulloch DK, Hosking DJ, Tobert A (1986) A pragmatic approach to sexual dysfunction in diabetic men: psychosexual counselling. Diabetic Med 3:485–489PubMedCrossRefGoogle Scholar
  48. 48.
    Mersdorf A, Goldsmith PC, Diederichs W, Padula C, Lue TF, Fishman IJ, Tanagho EA (1991) Ultrastructural changes in impotent penile tissue. A comparison of 65 patients. J Urol 145:749–758PubMedGoogle Scholar
  49. 49.
    Montague DK, Barada JK, Belker AM et al. (1996) Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. J Urol 156: 2007–2011PubMedCrossRefGoogle Scholar
  50. 50.
    Padma-Nathan H, Hellstrom WJG, Kaiser FE et al. (1997) Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 366/1:1–7CrossRefGoogle Scholar
  51. 51.
    Pfeiffer E, Verwoerdt A, Wang HS (1968) Sexual behavior in aged men and women. Arch Gen Psychiatr 19:735–758CrossRefGoogle Scholar
  52. 52.
    Porst H (1996) The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol 155:802–815PubMedCrossRefGoogle Scholar
  53. 53.
    Porst H (1997) Transurethral Alprostadil with MUSE™(medicated urethral system for erection) vs intracavernous Alprostadil — a comparative study in 103 patients with erectile dysfunction. Int J Impotence Research 9:187–192CrossRefGoogle Scholar
  54. 54.
    Price DE, Cooksey G, Jehu D, Bentley S, Hearnshaw JR, Osborn DE (1991) The management of impotence in diabetic men by vacuum tumescence therapy. Diabetic Med 8: 964–967PubMedCrossRefGoogle Scholar
  55. 55.
    Price DE, O’Malley BP, James M, Roshan M, Hearnshaw JR (1991) Why are impotent diabetic men not being treated? Practical Diabetes 8:10–11CrossRefGoogle Scholar
  56. 56.
    Rajfer J, Aronson WJ, Bush P, Dorey FJ, Ignarro LJ (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 326:90–94PubMedCrossRefGoogle Scholar
  57. 57.
    Reichel G, Neundörfer B (1996) Pathogenese und Therapie der peripheren diabetischen Polyneuropathien. Dtsch Arztebl 93/15:A-963–968Google Scholar
  58. 58.
    Ryder REJ, Marshall R, Johnson K, Ryder AP, Owens DR, Hayes TM (1988) Acetylcholine sweatspot test for autonomic denervation. Lancet 11303–1305PubMedCrossRefGoogle Scholar
  59. 59.
    Saenz de Tejada IS, Goldstein I, Azadzoi K, Krane RJ, Cohen RA (1989) Impaired neuro-genic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025–1030PubMedCrossRefGoogle Scholar
  60. 60.
    Sarica Y, Karucan I (1987) Bulbocavernosus reflex to somatic and visceral nerve stimulation in normal subjects and in diabetics with erectile impotence. J Urol 138:55–58PubMedGoogle Scholar
  61. 61.
    Schultheiss D, Truss MC, Becker AJ, Stief CG, Jonas U (1997) Dorsale Penisvenenligatur (DPVL) — Prognostische Faktoren und Langzeitresultate. Urologe [A] 36:351–355CrossRefGoogle Scholar
  62. 62.
    Schultheiss D, Truss MC, Becker AJ, Stief CG, Jonas U (1997) Long-term results following dorsal penile vein ligation in 126 patients with venoocclusive dysfunction. Int J Impotence Res 9:205–209CrossRefGoogle Scholar
  63. 63.
    Shabsigh R (1997) The effects of testosterone on the cavernous tissue and erectilefunction. World J Urol 15:21–26PubMedCrossRefGoogle Scholar
  64. 64.
    Sharaby JS, Benet AE, Melman A (1995) Penile revascularization. Urol Clin North Am 22/4:821–832PubMedGoogle Scholar
  65. 65.
    Singer DE, Nathan DM, Anderson KM, Wilson PWF, Evans JC (1992) Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 41:202–208PubMedCrossRefGoogle Scholar
  66. 66.
    Smith SA, Dewhirst RR (1986) A simple diagnostic test for pupillary abnormality in diabetic autonomic neuropathy. Diab Med 3:38–41CrossRefGoogle Scholar
  67. 67.
    Stief CG, Djamilian M, Schaebsdau F et al. (1990) Single potential analysis of cavernous electrical activity. A possible diagnosis of autonomic impotence. World J Urol 8:75–81CrossRefGoogle Scholar
  68. 68.
    Stief CG, Wetterauer U, Schaebsdau F, Jonas U (1991) Calcitonin-gene related peptide: a possible neurotransmitter in human penile erection. J Urol 146:1010–1014PubMedGoogle Scholar
  69. 69.
    Stief CG, Djamilian M, Truss MC, Tan H, Thon WF, Jonas U (1994) Prognostic factors for the postoperative outcome of penile venous surgery for venogenic erectile dysfunction. J Urol 151:880–883PubMedGoogle Scholar
  70. 70.
    Sullivan ME, Dashwood MR, Thompson CS, Muddle JR, Mikhailidis DP, Morgan RJ (1997) Alterations in endothelin B receptor sites in cavernosal tissue of diabetic rabbits: potential relevance to the pathogenesis of erectile dysfunction. J Urol 158:1966–1972PubMedCrossRefGoogle Scholar
  71. 71.
    Tesfamariam B, Kakubowski JA, Cohen RA (1989) Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TXA2. Am J Physiol 265: H219-H225Google Scholar
  72. 72.
    Truss MC, Becker AJ, Schultheiss D, Jonas U (1997) Intracavernous pharmacotherapy. World J Urol 15:71–77PubMedCrossRefGoogle Scholar
  73. 73.
    Uuisitupa MIJ, Niskanen LK, Siitonen O, Vouitilainen E, Pyorala K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175–1184CrossRefGoogle Scholar
  74. 74.
    Veves A, Webster L, Chen TF, Payne S, Boulton AJ (1995) Aetiopathogenesis and management of impotence in diabetic males: four years experience from acombined clinic. Diabet-Med 12/1:77–82PubMedCrossRefGoogle Scholar
  75. 75.
    Von Ferber L, Salzsieder E, Hauner H et al. (1993) Diabetes prevalence from health insurance data: evaluation of estimates by comparison with a population based diabetes register. Diabete Metab 19:89–95Google Scholar
  76. 76.
    Vrijhof HJ, Delaere KP (1994) Vacuum constriction devices in erectile dysfunction: acceptance and effectiveness in patients with impotence of organic or mixed aetiology. Br J Urol 74/1:102–105PubMedCrossRefGoogle Scholar
  77. 77.
    Wilson SK, Delk JR II (1995) Inflatable penile implant infection: predisposing factors and treatment suggestions. J Urol 153:659–661PubMedCrossRefGoogle Scholar
  78. 78.
    Yarnitsky D, Sprecher E, Vardi Y (1996) Penile thermal sensation. J Urol 156:391–393PubMedCrossRefGoogle Scholar
  79. 79.
    Ziegler D, Gries FA (1996) Diabetische Neuropathic Klassifiaktion, Epidemiologie, Prognose und sozialmedizinische Bedeutung. Dtsch Ärztebl 93/11: A-680–684Google Scholar
  80. 80.
    Zonszein J (1995) Diagnosis and management of endocrine disorders of erectile dysfunction. Urol Clin North Am 22/4:789–802PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • P. Schmidt
  • K. P. Jünemann
  • H. Derouet
  • W. H. Jost
  • S. Ückert
  • G. Popken
  • U. Wetterauer
  • H. M. Behre
  • U. Hartmann
  • W. F. Thon

There are no affiliations available

Personalised recommendations